mRNA medicineBioNTech
A biotechnology company developing mRNA medicines and cancer immunotherapies, and co-developer of the Pfizer-BioNTech COVID-19 vaccine.
At a glance
- Founded
- 2008
- Headquarters
- Mainz, Germany
- Category
- mRNA medicine · cancer immunotherapy
- Employees
- 8,052 · December 31, 2025
Consolidated group headcount, including CureVac.
Founders in the archive
Funding
Public company · Nasdaq: BNTX
Selected pre-IPO rounds below.
View financing details & sourcesOrigins & connections
Its research spans mRNA, immunotherapy and computational drug design. The 2023 InstaDeep acquisition expanded its work in AI-supported drug discovery.


